Lipoid pneumonia natural history, complications and prognosis
Lipoid pneumonia Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Lipoid pneumonia natural history, complications and prognosis On the Web |
American Roentgen Ray Society Images of Lipoid pneumonia natural history, complications and prognosis |
FDA on Lipoid pneumonia natural history, complications and prognosis |
CDC on Lipoid pneumonia natural history, complications and prognosis |
Lipoid pneumonia natural history, complications and prognosis in the news |
Blogs on Lipoid pneumonia natural history, complications and prognosis |
Risk calculators and risk factors for Lipoid pneumonia natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ramyar Ghandriz MD[2]
Overview
If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
OR
Common complications of [disease name] include [complication 1], [complication 2], and [complication 3].
OR
Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%.
Natural History, Complications, and Prognosis
- Patients might present acutely with inflammation and cough, fever, and dyspnea. However, they might be asymptomatic and present with an incidental mass on radiographs.
- Owing to its nonspecific symptoms and radiological features, lipoid pneumonia often remains undiagnosed or diagnosis is delayed.
- The oil released illicits a giant-cell granulomatous reaction (hence also called lipid granulomatosis), chronic inflammation, and alveolar and interstitial fibrosis
- Evolution of lesions with time has been described:
- Fresh lesions show alveolar infiltration by lipid-laden macrophages and almost normal alveolar walls and septa
- Advanced lesions show larger vacuoles and inflammatory infiltrates in alveolar walls, bronchial walls and septa